Observed arrival · 2026-10-14
GLP Guidebook maps GLP-1 medicines by country
An independent-guide site covering GLP-1 medicines, their effects and side effects, and country-specific prescribing rules, prices, and coverage.
- For
- People comparing GLP-1 medicine rules across countries
- Worth noticing
- Its country menu spans nine markets, from India and the United States to France, Germany, and Saudi Arabia.
Field notes
The landing page separates medicine-level entries—semaglutide, tirzepatide, liraglutide, and dulaglutide—from country guides. It lists nine markets, including India, the UK, Australia, Canada, the UAE, the US, France, Germany, and Saudi Arabia, with locally relevant topics such as rupee prices, NHS/NICE rules, PBS coverage, and provincial coverage. The page says it uses published sources and takes no money from drug makers or sellers; that sourcing claim is not independently verifiable from this extract.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue